(IBC3) Core MSCI EM IMI - Overview
Etf: ETF, Equities, Emerging, Markets, Index
Dividends
| Dividend Yield | 2.47% |
| Yield on Cost 5y | 2.72% |
| Yield CAGR 5y | 3.49% |
| Payout Consistency | 95.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.5% |
| Relative Tail Risk | -2.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.05 |
| Alpha | 17.08 |
| Character TTM | |
|---|---|
| Beta | 0.215 |
| Beta Downside | 0.470 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.08% |
| CAGR/Max DD | 0.77 |
Description: IBC3 Core MSCI EM IMI December 19, 2025
The iShares Core MSCI EM IMI UCITS ETF (XETRA: IBC3) tracks the Morningstar Emerging Markets Total Market Index (EM TME NR USD), offering broad exposure to large-, mid- and small-cap equities across 26 emerging economies. It is domiciled in Germany, classified as a Global Emerging Markets Equity ETF, and trades under the ticker IBC3.
Key metrics as of the latest reporting period include an expense ratio of 0.20 % and total net assets of roughly €7 bn, making it one of the larger EM ETFs in Europe. The fund’s top sector allocations are Financials (≈ 20 %), Consumer Discretionary (≈ 15 %) and Technology (≈ 12 %), reflecting the growth-driven composition of markets such as China, India and Brazil. Recent performance has been closely tied to commodity price cycles and the pace of monetary tightening in the U.S., both of which influence capital flows into emerging markets.
For a deeper, data-driven look at IBC3’s risk-adjusted returns and scenario analysis, you may find ValueRay’s analytics platform worth exploring.
What is the price of IBC3 shares?
Over the past week, the price has changed by +0.88%, over one month by +3.18%, over three months by +7.94% and over the past year by +24.19%.
Is IBC3 a buy, sell or hold?
What are the forecasts/targets for the IBC3 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 6.3 | 12.1% |
IBC3 Fundamental Data Overview February 04, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 19.95b EUR (19.95b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 19.95b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 19.95b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.71% (E(19.95b)/V(19.95b) * Re(6.71%) + (debt-free company))
Discount Rate = 6.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)